Intravenous Fosfomycin for Gram-Negative and Gram-Positive Bacterial Infections: A Systematic Review of the Clinical Evidence [PDF]
Matthew E. Falagas +5 more
openalex +1 more source
Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review. [PDF]
Marino A +12 more
europepmc +1 more source
Infección Interdigital Por Bacterias Gram Negativas / Gram-Negative Bacterial Interdigital Infection
Andrea Silva-Casais +2 more
openalex +2 more sources
Efficacy and safety of ceftazidime-avibactam versus standard antibiotic therapy for resistant Gram-negative bacterial infections: a systematic review and meta-analysis. [PDF]
Li J, Dong Z, Tang L, Liu L, Yu S.
europepmc +1 more source
A Comparative Study of Ceftazidime-Avibactam and Meropenem-Based Regimens in the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections in Intensive Care Units. [PDF]
Aydın M +3 more
europepmc +1 more source
Harnessing endogenous anti-glycan antibodies using a novel, bifunctional immunotherapy to treat gram-negative bacterial infections. [PDF]
Hairsine B +10 more
europepmc +1 more source
Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps. [PDF]
Yeoh DK +17 more
europepmc +1 more source
2334. Risk Factors of Multidrug-Resistant Gram-Negative Bacterial Bloodstream Infections in Children’s Hospitals in Japan [PDF]
Yuta Aizawa +8 more
openalex +1 more source
Antineutrophil Cytoplasmic Autoantibodies Specific to Bactericidal/Permeability-Increasing Protein: A Cross-Road Between Prolonged Gram-Negative Bacterial Infections and Ulcerative Colitis/Primary Sclerosing Cholangitis. [PDF]
Jovanovic D +7 more
europepmc +1 more source
Estimated undertreatment of carbapenem-resistant Gram-negative bacterial infections in eight low-income and middle-income countries: a modelling study. [PDF]
Mishra A +4 more
europepmc +1 more source

